Manuel Vazquez-Carrera

Dr. Manuel Vazquez-Carrera

Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain, and Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM)-Instituto de Salud Carlos III, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1996 in Nature
Verified
Journal Article
Closed access
PDF file
PDPallavi R. Devchand
Pallavi R. Devchand
HKHansjörg Keller
Hansjörg Keller
JPJeffrey M. Peters
Jeffrey M. Peters
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera
FGFrank J. Gonzalez
Frank J. Gonzalez
WWWalter Wahli
Walter Wahli

1 March 2018 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
XPXavier Palomer
Xavier Palomer
JPJavier Pizarro-Delgado
Javier Pizarro-Delgado
Emma BarrosoEmma Barroso
Emma Barroso
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera

1 April 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TCTeresa Coll
Teresa Coll
EEElena Eyre
Elena Eyre
RRRicardo Rodríguez-Calvo
Ricardo Rodríguez-Calvo
XPXavier Palomer
Xavier Palomer
RSRosa M. Sánchez
Rosa M. Sánchez
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera
Here we report that in skeletal muscle cells the contribution to insulin resistance and inflammation of two common dietary long-chain fatty acids depends on the channeling of these lipids to distinct cellular metabolic fates. Exposure of cells to the saturated fatty acid palmitate led to enhanced diacylglycerol levels and the consequent activation of the protein kinase Cθ/nuclear factor κB pathway, finally resulting in enhanced interleukin 6 secretion and down-regulation of the expression of genes involved in the control of the oxidative capacity of skeletal muscle (peroxisome proliferator-activated receptor (PPAR)γ-coactivator 1α) and triglyceride synthesis (acyl-coenzyme A: diacylglycerol acyltransferase 2). In contrast, exposure to the monounsaturated fatty acid oleate did not lead to these changes. Interestingly, co-incubation of cells with palmitate and oleate reversed both inflammation and impairment of insulin signaling by channeling palmitate into triglycerides and by up-regulating the expression of genes involved in mitochondrial β-oxidation, thus reducing its incorporation into diacylglycerol. Our findings support a model of cellular lipid metabolism in which oleate protects against palmitate-induced inflammation and insulin resistance in skeletal muscle cells by promoting triglyceride accumulation and mitochondrial β-oxidation through PPARα- and protein kinase A-dependent mechanisms.

1 January 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TLThomas Lemberger
Thomas Lemberger
RSRégis Saladin
Régis Saladin
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera
FAFrançoise Assimacopoulos
Françoise Assimacopoulos
BSBart Staels
Bart Staels
JAJohan Auwerx
Johan Auwerx
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that can be activated by fatty acids and peroxisome proliferators. The PPARα subtype mediates the pleiotropic effects of these activators in liver and regulates several target genes involved in fatty acid catabolism. In primary hepatocytes cultured in vitro, the PPARα gene is regulated at the transcriptional level by glucocorticoids. We investigated if this hormonal regulation also occurs in the whole animal in physiological situations leading to increased plasma corticosterone levels in rats. We show here that an immobilization stress is a potent and rapid stimulator of PPARα expression in liver but not in hippocampus. The injection of the synthetic glucocorticoid dexamethasone into adult rats produces a similar increase in PPARα expression in liver, whereas the administration of the antiglucocorticoid RU 486 inhibits the stress-dependent stimulation. We conclude that glucocorticoids are major mediators of the stress response. Consistent with this hormonal regulation, hepatic PPARα mRNA and protein levels follow a diurnal rhythm, which parallels that of circulating corticosterone. To test the effects of variations in PPARα expression on PPARα target gene activity, high glucocorticoid-dependent PPARα expression was mimicked in cultured primary hepatocytes. Under these conditions, hormonal stimulation of receptor expression synergizes with receptor activation by WY-14,643 to induce the expression of the PPARα target gene acyl-CoA oxidase. Together, these results show that regulation of the PPARα expression levels efficiently modulates PPAR activator signaling and thus may affect downstream metabolic pathways involved in lipid homeostasis.

1 October 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
XPXavier Palomer
Xavier Palomer
LSLaia Salvadó
Laia Salvadó
Emma BarrosoEmma Barroso
Emma Barroso
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera

1 August 2015 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
LSLaia Salvadó
Laia Salvadó
XPXavier Palomer
Xavier Palomer
Emma BarrosoEmma Barroso
Emma Barroso
Manuel Vazquez-CarreraManuel Vazquez-Carrera
Manuel Vazquez-Carrera